{
  "id": 9155622,
  "title": "Amgen's Phase 3 Sjögren's win; Novartis' $900M radioligand deal",
  "url": "https://urgent.news/2026/09/22/amgens-phase-3-sjogrens-win-novartis-900m-radioligand-deal",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-22T15:29:54.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/amgens-phase-3-sjogrens-win-novartis-900m-radioligand-deal/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Plus news about Boehringer, Envisagenics, Ionis, Otsuka, Merck, Lexeo and Mantle. Amgen gets a win from Horizon buyout: Amgen said dazodalibep, a CD40 ligand antagonist, succeeded in a Phase ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}